Abstract: . . .  the role of beta blockers in atrial fibrillation prophylaxis resulted in significant improvement in post-operative atrial fibrillation rates. Continued monitoring of the atrial fibrillation rate will be necessary to assure that this quality improvement is sustained. Further research should address contraindications to beta blocker administration and the incidence of atrial fibrillation in the population who did not receive beta blockers vs. the population who did receive beta blocker administration.  . . .
--814,1,407,643,4068